COVID-19 Complications and Co-Infections: 2nd Edition
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 31 December 2026 | Viewed by 18
Special Issue Editors
Interests: COVID-19 infection; vaccination hesitancy; gender disparities; racial disparities; hospital medicine; COVID-19 complications
Special Issues, Collections and Topics in MDPI journals
Interests: COVID-19; acute respiratory distress syndrome; asthma; COPD
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since the outbreak of the COVID-19 pandemic in 2019, our understanding of the disease has undergone rapid development. We have gained significant insights into COVID-19, including its risk factors, pathophysiology, clinical course, outcomes, complications, prognosis, associated co-morbid conditions and co-infections, as well as optimal treatment and management options. However, despite these advancements, there are still notable gaps in our knowledge, especially as new variants continue to evolve and the long-term consequences of infection become increasingly apparent.
Building on the success of our first volume, this second Special Issue continues to examine the evolving landscape of short- and long-term clinical outcomes of COVID-19 and its associated co-infections. With the pandemic entering a new phase, understanding the impact of successive variants, waning immunity, and the burden of post-COVID-19 condition (Long COVID) is more critical than ever. We especially welcome the following contributions:
- Virology research that presents original empirical studies (using qualitative, mixed, and quantitative methods), systematic reviews, short communications, case reports, and brief reports. We are particularly interested in studies that contribute to our understanding of the course, outcomes, and prognosis of COVID-19 caused by emerging variants, as well as the pathogenesis and long-term sequelae of the disease.
- Research on multi-organ complications associated with COVID-19, which include cardiovascular disease, thrombosis, kidney damage, neurological conditions, and gastrointestinal symptoms. These complications, together with co-infections and superinfections such as bacterial pneumonia, influenza virus infection, and fungal infections (e.g., COVID-19-associated pulmonary aspergillosis), can significantly increase the severity, complexity, and mortality of the disease.
- Critical perspectives and articles that examine how clinical and public health initiatives and interventions can effectively reduce morbidity, mortality, and the burden on healthcare systems caused by COVID-19 and its complications. Submissions evaluating the real-world effectiveness of treatments and management strategies in the context of co-infections and a widely vaccinated population are crucial.
Understanding the nature of these complications and co-infections in the current phase of the pandemic is vital for informing strategies to effectively manage and treat COVID-19. We aim to bridge existing knowledge gaps and advance our understanding of this complex disease. Global perspectives in submissions are welcome.
Dr. Abu Baker Sheikh
Dr. Adeel Nasrullah
Dr. Amir Humza Sohail
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- COVID-19
- complications
- co-infections
- hospitalization
- risk factors
- pathophysiology
- clinical course
- outcomes
- prognosis
- associated co-morbid conditions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
Related Special Issue
- COVID-19 Complications and Co-infections in Viruses (22 articles)
